Back to Weight Loss & Metabolic
TrendingRetatrutide 10mg lyophilized peptide vial — Healthy Aminos, ≥98% purity
Weight Loss & Metabolic

Retatrutide Peptide

10mg · Lyophilized Powder · ≥98%

Retatrutide is a triple agonist targeting GIP, GLP-1, and glucagon receptors simultaneously — the first peptide to engage all three pathways. Early phase clinical trial results published in the New England Journal of Medicine showed dose-dependent responses across metabolic parameters. The triple-agonist mechanism is a novel approach that goes beyond existing dual-agonist compounds.

Select Size

Batch Information

Batch ID
Purity≥98%
FormLyophilized powder
Storage-20°C, protect from light
Third-party COA verified · 6-point testing protocol
View COA →
$64.99
1
≥98% Purity Verified
Independent COA
Free Shipping $150+
Research Use Only

Retatrutide

$64.99

Research Use Only

FOR RESEARCH USE ONLY. Products sold by Healthy Aminos are intended strictly for in-vitro research and laboratory use. Not for human or animal consumption. Not FDA approved. By purchasing from Healthy Aminos, the buyer acknowledges that these products are not intended to diagnose, treat, cure, or prevent any disease. All products are sold as reference standards and research chemicals only.

Loading COA data...

Compound Specifications

Molecular Weight4603.28 Da
Molecular FormulaC213H336N46O66S
CAS Number2381089-83-2
Synonyms
HA-RT3, LY3437943, GGG tri-agonist
Research Applications
Triple incretin signalingMetabolic researchThermogenesisLipolysisGIP/GLP-1/glucagon pathway

Research Context

Triple agonist engaging GIP receptor, GLP-1 receptor, and glucagon receptor. The glucagon component adds thermogenic and lipolytic signaling pathways not present in GLP-1-only or dual GIP/GLP-1 compounds.

View published research

Retatrutide Published Research

Retatrutide (LY3437943) is a triple agonist peptide targeting GIP, GLP-1, and glucagon receptors simultaneously. It represents a novel approach in incretin-based research, combining three receptor activities in a single molecule. Phase 2 clinical trial results were published in 2023.

Triple Receptor Agonism

Published research has characterized retatrutide's activity at three distinct receptors: GIP, GLP-1, and glucagon receptors. Studies have examined the relative potency at each receptor and the theoretical additive or synergistic effects of combined receptor activation. The glucagon receptor component distinguishes it from dual agonists like tirzepatide.

Phase 2 Clinical Research

Phase 2 clinical trial data published in the New England Journal of Medicine examined retatrutide across multiple dose levels in a 48-week randomized, double-blind, placebo-controlled trial. The study enrolled 338 participants and examined metabolic and body composition endpoints at 12mg dose levels. This represents the most advanced published data on a triple-agonist peptide.

References

Triple-hormone-receptor agonist retatrutide for obesityN Engl J Med (2023). PMID: 37385275

The studies referenced above are presented for informational purposes only and do not constitute medical claims. All Healthy Aminos products are sold for research use only and are not intended for human consumption.

Frequently Asked Questions About Retatrutide

What is Retatrutide peptide?
Retatrutide is a research-grade peptide available from Healthy Aminos. Retatrutide is a triple agonist targeting GIP, GLP-1, and glucagon receptors simultaneously — the first peptide to engage all three pathways. Early phase clinical trial results published in the New England Journal of Medicine showed dose-dependent responses across metabolic parameters. The triple-agonist mechanism is a novel approach that goes beyond existing dual-agonist compounds. It is supplied in lyophilized (freeze-dried) form for laboratory research use only.
What purity is Healthy Aminos Retatrutide?
Our Retatrutide is verified at ≥98% purity via HPLC analysis. Each batch includes an independent third-party Certificate of Analysis (COA) with HPLC chromatogram and mass spectrometry confirmation.
How should I store Retatrutide?
Retatrutide should be stored at -20°C, protect from light for long-term storage or 2-8°C for short-term use. Keep sealed, away from light and moisture. Lyophilized peptides maintain stability for 24+ months when stored properly.
Does Healthy Aminos Retatrutide come with a COA?
Yes. Every batch of Retatrutide ships with a batch-specific Certificate of Analysis including HPLC purity, mass spectrometry confirmation, endotoxin testing, sterility testing, and peptide content verification.
What is the molecular weight of Retatrutide?
Retatrutide has a molecular weight of 4603.28 Da. Its molecular formula is C213H336N46O66S.
Is Retatrutide legal to purchase?
Retatrutide is sold as a Research Use Only (RUO) chemical reference standard. It is legal to purchase in the United States for legitimate scientific research. It is not approved by the FDA for any diagnostic, therapeutic, or clinical purpose.

Related Weight Loss & Metabolic Peptides

Weight Loss & Metabolic
Popular
Semaglutide 10mg lyophilized peptide vial — Healthy Aminos

Semaglutide

10mg · Lyophilized powder

Semaglutide is a 31-amino acid GLP-1 receptor agonist based on the GLP-1(7-37) sequence with two key modifications: an Aib substitution at position 8 (protects against DPP-4 degradation) and a C-18 fatty diacid linker at position 26 (albumin binding for half-life extension). It has been studied in multiple large-scale clinical trial programs including SUSTAIN, PIONEER, and STEP, with over 20,000 total trial participants.

HA-SEMA-2026A
MW: 4113.58 Da
COA Verified · ≥98%
Weight Loss & Metabolic
New
Tirzepatide 10mg lyophilized peptide vial — Healthy Aminos

Tirzepatide

10mg · Lyophilized powder

Tirzepatide is a 39-amino acid dual GIP/GLP-1 receptor agonist based on the native GIP sequence. It incorporates a C-20 fatty diacid moiety for albumin binding and includes amino acid substitutions enabling GLP-1R cross-reactivity while maintaining GIPR activity. Studied in the SURPASS and SURMOUNT clinical trial programs with over 15,000 participants. The SURPASS-2 trial is the only published head-to-head comparison with semaglutide.

HA-TIRZ-2026A
MW: 4813.53 Da
COA Verified · ≥98%

Research Use Only

FOR RESEARCH USE ONLY. Products sold by Healthy Aminos are intended strictly for in-vitro research and laboratory use. Not for human or animal consumption. Not FDA approved. By purchasing from Healthy Aminos, the buyer acknowledges that these products are not intended to diagnose, treat, cure, or prevent any disease. All products are sold as reference standards and research chemicals only.